A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial
American Heart Journal, vol. 231 Doi: 10.1016/j.ahj.2020.10.001
